Outset Medical, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M |
| Cost of revenue | $72.7M | $75.1M | $101.4M | $97.5M | $95.0M |
| Gross profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M |
| Research and development | $21.2M | $38.4M | $57.3M | $48.9M | $36.7M |
| Operating expenses | $113.5M | $151.9M | $198.8M | $178.9M | $138.1M |
| Operating income | -$66.7M | -$113.4M | -$169.8M | -$161.0M | -$130.5M |
| Interest expense | $14.0M | $23.9M | $12.7M | $3.6M | $1.7M |
| Pretax income | -$80.9M | -$127.5M | -$172.3M | -$162.7M | -$131.7M |
| Income tax expense | $718,000 | $491,000 | $523,000 | $295,000 | $199,000 |
| Net income | -$81.7M | -$128.0M | -$172.8M | -$163.0M | -$131.9M |
| Balance Sheet | |||||
| Cash and equivalents | $35.0M | $124.0M | $68.5M | $73.2M | $182.3M |
| Current assets | $250.9M | $258.2M | $291.2M | $373.6M | $409.8M |
| Total assets | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M |
| Current liabilities | $37.6M | $45.4M | $55.3M | $51.9M | $51.7M |
| Total liabilities | $137.5M | $249.0M | $190.9M | $154.1M | $89.4M |
| Stockholders' equity | $127.0M | $26.8M | $122.9M | $246.0M | $374.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$46.3M | -$116.3M | -$131.4M | -$145.7M | -$130.3M |
| Depreciation and amortization | $4.3M | $5.7M | $5.8M | $5.2M | $5.2M |
| Stock-based compensation | $15.6M | $29.4M | $38.6M | $27.2M | $17.4M |
| Capital expenditure | $798,000 | $912,000 | $3.4M | $8.3M | $3.1M |
| Free cash flow | -$47.1M | -$117.2M | -$134.8M | -$154.1M | -$133.4M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 18.5M · Free float 74.4%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.